FDA Expands Use of Approved Breast Cancer Drug
WWW.FIGHTPINK.ORG - The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.HER2 is a protein involved in normal cell growth. It is found on some types of cancer cells, including breast cancer cells. In [...]
From the Front Page
- Comments
- Tweets (7)
Tweets
Sorry there have been no tweets in the last 7 days.
